Medtech Convergence
Venture capitalBoston · 2 people tracked
Find your way into Medtech Convergence
Fund manager profile
Medtech Convergence is a venture fund manager based in Boston. SEC filings show 1 venture fund on record, most recently Medtech Convergence Fund, L.P. ($94M offering) filed March 2019.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 2 people
from public directoriesWhat they invest in
from 1 of 1 portfolio companiesBiotech ×1FemTech ×1Medical Devices ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro path
Nanopath is developing a molecular diagnostic platform for point-of-care disease diagnosis, with a focus on women's health.
BiotechFemTechMedical DevicesCambridge, US
Alison Burklund(Executive Officer, Director)inAmogha Tadimety(Executive Officer, Director)in
BoardAaron Sandoski(Director)inJeff Crowe(Director)
Co-investorsNorwest Venture PartnersService Provider CapitalGingerbread CapitalNorwich VenturesSV Health Investors
Portfolio news
latest coverage across their companiesNanopath · prnewswire.com · Oct 16, 2025
Frequently asked questions
- Where is Medtech Convergence located?
- Medtech Convergence is headquartered in Boston, US.